Patterson Companies, Inc. (PDCO) News
Filter PDCO News Items
PDCO News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
PDCO News Highlights
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
Latest PDCO News From Around the Web
Below are the latest news stories about PATTERSON COMPANIES INC that investors may wish to consider to help them evaluate PDCO as an investment opportunity.
PDCO Stock Gains on the News of Acquisition Deal With Patient SquarePatterson enters into a definitive agreement to be acquired by Patient Square Capital at a valuation of approximately $4.1 billion. |
Walgreens Boots Alliance, Alaska Air And RH Are Among Top Mid-Cap Gainers Last Week (December 9-13): Are The Others In Your Portfolio?These ten mid-cap stocks were the best performers in the last week. Are they in your portfolio? Patterson Companies, Inc. (NASDAQ:PDCO) stock rocketed 35.60% after the company announced it entered into a definitive agreement to be acquired by Patient Square Capital for approximately $4.1 billion. NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) shares jumped 34.55% after the company announced topline data from its Phase 3 BROADWAY trial of Obicetrapib. Walgreens Boots Alliance, Inc. (NASDAQ:WBA) g |
What Does Dental Player Patterson's $4.1 Billion Deal Mean For Other Players?On Wednesday, Patient Square Capital, a healthcare investment firm, agreed to acquire Patterson Companies, Inc. (NASDAQ:PDCO), a dental and animal health product distributor, for approximately $4.1 billion. During its second-quarter earnings release, the company announced it is exploring strategic options, including a sale or merger, to boost shareholder value. William Blair notes that based on Patient Square Capital’s portfolio, which doesn’t include dental or animal health companies, regulator |
Patterson Launches On $4.1 Billion Takeover. Can It Reinvigorate The Beleaguered Dental Space?Patterson Companies stock launched Wednesday after the dental outfit said it agreed to a $4.1 billion takeover deal from Patient Square. |
Patterson Companies Surges 34% as Patient Square Capital Plans $4.1B Private BuyoutPatient Square Capital acquires Patterson Companies for $4.1B, offering a 35.7% premium per share. |
Patterson Companies Stock Soars Over 30% After $4.1 Billion Acquisition DealShareholders will receive $31.35 per share in cash, representing a significant premium over recent trading prices. |
Patterson Companies Soars 35% on $4.1 Billion Buyout: A Game-Changer for Dental Stocks?Private equity giant Patient Square Capital bets big on Patterson, shaking up the struggling dental market. |
Dental Product Supplier Patterson Companies Goes Private In $4.1 Billion DealOn Wednesday, Patient Square Capital, a healthcare investment firm, agreed to acquire Patterson Companies, Inc. (NASDAQ:PDCO), a dental and animal health product distributor, for approximately $4.1 billion. Under the terms of the agreement, Patterson shareholders will receive $31.35 in cash per share, representing an approximately 49% premium to Patterson’s 30 calendar-day volume-weighted average price (VWAP) ending December 4, 2024 (the last trading day before Patterson announcing the evaluatio |
Patterson Cos. Stock Surges 34% on $4.1 Billion Acquisition by Patient SquarePatterson Cos. stock rose sharply Wednesday after the company announced it would be acquired by private-equity firm Patient Square Capital in a $4.1 billion deal. Shares of the healthcare distributor jumped 34% to $31.10, marking the largest same-day percent increase on record, according to Dow Jones Market Data. Patterson a distributor specializing in equipment for the animal health and dental markets, went up for sale after posting mixed earnings for its second fiscal quarter ended Oct. 26. |
Patterson Cos to Be Acquired by Patient Square in $4.1 Billion DealThe dental and animal health-care company agreed to be acquired by health-care investment firm Patient Square Capital in a deal valued around $4.1 billion. |